Table 3.
Sample | MLST Type | Growth Inhibition (%) 1 | EC50 (µg/mL) |
---|---|---|---|
56 | 26-a | 80.00 | 1.2 |
57 | 26-a | 82.05 | 1.2 |
58 | 26-a | 80.00 | 1.2 |
59 | 26-a | 80.56 | 1.5 |
60 | 26-a | 81.58 | 2.3 |
61 | 26-a | 80.56 | 5.8 |
62 | 26-a | 80.00 | 1.9 |
63 | 26-a | 80.00 | 1.3 |
64 | 26-a | 80.00 | 2.7 |
65 | 26-a | 80.00 | 3.2 |
66 | 26-a | 80.56 | 1.9 |
67 | 26-a | 80.00 | 1.6 |
52 | Equiseti | 100.00 | 2.6 |
53 | Equiseti | 100.00 | 2.6 |
54 | Equiseti | 100.00 | 3.6 |
55 | Equiseti | 100.00 | 1.8 |
1 Growth inhibition was determined for 10 µg/mL of tebuconazole.